Skip to content
★ Sign in to follow
Medinex Limited logo

Medinex Limited Stock: price and insider trades · Singapore

ISIN SGXE82839874SG·Mcap SGD 26.9M

No insider purchase over the last 90 days. The latest, by Jessie Low Mui Choo, was filed 05 Aug 2026.

Medinex Limited: what insiders have been doing

Medinex Limited is a listed company. Its insiders report their share dealings to SGX. The last twelve months, up to 20 October 2026, brought 3 filings signed by 3 insiders.

Purchases and sales both appear in the filings: 2 purchases (2 insiders, €62k) and 1 sale (1 insider). No amount is published for 2 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 2 chief executives. One trade stands out by size: a purchase of €62k from Jessie Low Mui Choo, disclosed on 5 August 2026, or 0.35% of market capitalisation.

With 3 filings in twelve months, the company is quieter than the median of 6 filings across the 393 companies we follow on the same exchange. Our records for Medinex Limited go back to 2018, with 20 purchases and 1 sale on the open market in total.

The clock since the last published purchase (5 August 2026) now reads 95 days.

These figures are compiled from regulatory filings published by SGX. They describe what insiders did and are not a recommendation.

Insider Decl.
30
Thresholds
n/a
Buy Volume
€2M
20 ops. · all time
Sell Volume
n/a
1 ops. · all time

Who traded when

BuySale
Jessie Low Mui Choo2 buys
Tan Lee Meng1 buy
Tan Tin Nam1 sale

Since the insiders bought

  • Filed 05 Aug 2026 · 95 days ago · €62k
    -9.1%
    Entry SGD 0.22 · Close 16 Oct 2026 SGD 0.20
  • Filed 19 Jan 2022 · 1754 days ago · €61k
    -8.7%
    Entry SGD 0.23 · Close at T+365 SGD 0.21
  • Filed 07 Dec 2018 · 2893 days ago · €38k
    -9.1%
    Entry SGD 0.28 · Close at T+365 SGD 0.25

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 1,578 of 26,911 companies
78.0
score / 100
Value
73
Quality
83
FCF yld9.5%
Earn yld8.3%
EV/EBITDA9.3x
ROE13%
Gross mgn80%
Net mgn18%
Debt/EBITDA0.3x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

SGD 0.20
Analyst consensus
·
Income statement
RevenueSGD 12.4M
Gross profitSGD 10M80% margin
EBITDASGD 3M24% margin
Net incomeSGD 2.2M17.9% margin
Valuation
PER (trailing)10.0x
P/Book1.6x
Beta0.17
Balance sheet & cash
Market capSGD 26.9M
Total debtSGD 995.7k
Free Cash FlowSGD 2.5M
Debt / Equity6%
Profitability & ownership
ROE13.4%
ROA9.0%
% insiders85.4%
% institutions0.0%
Last declaration on 5 August 2026
Declarations30 total
  • ▲
    Director/CEOExecutives
    92,000 SGD45SGX
    400,000 shares@ SGD 0.230.35% mcap100.0% of flowShareSGX-STISIN SGXE82839874SGX:K7RQJJRKRFC7D6Y4
    Canonical exit: 3 Nov 2026 (T+90)
  • ▲
    Director/CEOExecutives
    0SGX
    8,674,460 sharesShareSGX-STISIN SGXE82839874SGX:QU0REV836RQ2TUT1
    Canonical exit: 19 Aug 2026 (T+90)
  • ▼
    Substantial ShareholderExecutives(filed)
    0SGX
    8,674,460 sharesShareSGX-STISIN SGXE82839874SGX:LP38MFE4LW7I9M7D
  • ▲
    Director/CEOExecutives
    0SGX
    799,800 sharesShareSGX-STISIN SGXE82839874SGX:ZJ92GDC38VDZO7YF
    Canonical exit: 9 Jun 2025 (T+90)
  • ▲
    Director/CEOExecutives
    22,000 SGD23SGX
    100,000 shares@ SGD 0.2213.9% of flowShareSGX-STISIN SGXE82839874SGX:BQ5XWS1ZE3T5B01E
    Canonical exit: 20 Mar 2023 (T+90)
  • ▲
    Director/CEOExecutives
    46,000 SGD25SGX
    200,000 shares@ SGD 0.2329.4% of flowShareSGX-STISIN SGXE82839874SGX:DGFPSBH4TPNN86QM
    Canonical exit: 5 Oct 2022 (T+90)
  • ▲
    Director/CEOExecutives
    93,668 SGD30SGX
    416,300 shares@ SGD 0.225100.0% of flowShareSGX-STISIN SGXE82839874SGX:EINJYSZPDGTSD4GS
    Canonical exit: 18 Apr 2022 (T+90)
  • ●
    Director/CEOExecutives(filed)
    0SGX
    ShareSGX-STISIN SGXE82839874SGX:81NQAUKV6Q9ONGK4
  • ▲
    Director/CEOExecutives
    714 SGD22SGX
    3,300 shares@ SGD 0.21640.7% of flowShareSGX-STISIN SGXE82839874SGX:FF99ARNVSC7OIB6M
    Canonical exit: 6 Sept 2020 (T+90)
  • ▲
    Director/CEOExecutives
    4,200 SGD22SGX
    20,000 shares@ SGD 0.214.2% of flowShareSGX-STISIN SGXE82839874SGX:EX33FXZGJ7EWIZD7
    Canonical exit: 26 Aug 2020 (T+90)
  • ▲
    Director/CEOExecutives
    3,750 SGD22SGX
    15,000 shares@ SGD 0.251.8% of flowShareSGX-STISIN SGXE82839874SGX:0SGGUFM6XFRVBCKR
    Canonical exit: 24 May 2020 (T+90)
  • ▲
    Director/CEOExecutives
    225 SGD22SGX
    900 shares@ SGD 0.250.1% of flowShareSGX-STISIN SGXE82839874SGX:S33LJBXHIU8POP7V
    Canonical exit: 17 May 2020 (T+90)
  • ▲
    Director/CEOExecutives
    18,050 SGD23SGX
    72,200 shares@ SGD 0.258.8% of flowShareSGX-STISIN SGXE82839874SGX:HCTY04VXAMH7AK1W
    Canonical exit: 7 May 2020 (T+90)
  • ●
    Director/CEOExecutives
    0SGX
    ShareSGX-STISIN SGXE82839874SGX:346XY4GN0JM3EWHK
  • ▲
    Director/CEOExecutives
    0SGX
    10,000 sharesShareSGX-STISIN SGXE82839874SGX:4NIU1PV3IDQ0UX29
    Canonical exit: 7 Jan 2020 (T+90)
  • ▲
    Director/CEOExecutives
    14,800 SGD23SGX
    59,200 shares@ SGD 0.257.3% of flowShareSGX-STISIN SGXE82839874SGX:L9GO0FIMF5LK08W8
    Canonical exit: 6 Jan 2020 (T+90)
  • ▲
    Director/CEOExecutives
    0SGX
    130,000 sharesShareSGX-STISIN SGXE82839874SGX:5Z4R5EV13Z2JB0VG
    Canonical exit: 24 Apr 2019 (T+90)
  • ▲
    Director/CEOExecutives
    102,600 SGD30SGX
    380,000 shares@ SGD 0.27100.0% of flowShareSGX-STISIN SGXE82839874SGX:MV7N9ZOVUW48KOS4
    Canonical exit: 24 Apr 2019 (T+90)
  • ▲
    Substantial ShareholderExecutives(filed)
    60,000 SGD31SGX
    240,000 shares@ SGD 0.25100.0% of flowShareSGX-STISIN SGXE82839874SGX:TBLD71S61NZ8S4GT
    Canonical exit: 7 Mar 2019 (T+90)
  • ▲
    Substantial ShareholderExecutives(filed)
    500,000 SGD31SGX
    2,000,000 shares@ SGD 0.25100.0% of flowShareSGX-STISIN SGXE82839874SGX:6P0Y4ZZPWI76RRS0
    Canonical exit: 7 Mar 2019 (T+90)
  • ▲
    Substantial ShareholderExecutives(filed)
    500,000 SGD28SGX
    2,000,000 shares@ SGD 0.25100.0% of flowShareSGX-STISIN SGXE82839874SGX:68007L512M13ZH0A
    Canonical exit: 7 Mar 2019 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    500,000 SGD25SGX
    2,000,000 shares@ SGD 0.25100.0% of flowShareSGX-STISIN SGXE82839874SGX:R6FS5TGDAKLE6LN4
    Canonical exit: 7 Mar 2019 (T+90)
  • ●
    Related company / holdingExecutives(filed)
    0SGX
    ShareSGX-STISIN SGXE82839874SGX:QH26KA0I94G8UNCR
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SGXE82839874SGX:EDV2TQCDFHEMFOZP
  • ●
    Substantial ShareholderExecutives(filed)
    0SGX
    ShareSGX-STISIN SGXE82839874SGX:W0SKQTRXY42FGODJ

25 of 30 declarations

About Medinex Limited

Medinex Limited is a company listed on the XSES market, specializing in the healthcare sector. It focuses on the development and distribution of innovative medical solutions.